Owkin
Johanna Husson is a Corporate Development Manager at Owkin since March 2023, specializing in competitive intelligence, strategic partnerships, and due diligence for in-licensing assets. Prior experience includes serving as a Team Leader Consultant at Health Advances from January 2020 to March 2023, where Johanna delivered projects focused on corporate and portfolio strategies, market access, and due diligence. Earlier roles include Senior Analyst and Analyst at Eurazeo in 2019, with a focus on investments in early-stage digital health companies, and a Research Intern at Columbia University Irving Medical Center, conducting lab research in neurobiology. Johanna holds a Master in Management from HEC Paris and has completed a CEMS exchange semester at the University of St.Gallen, along with a Master's in Engineering in Biotechnology from AgroParisTech.
This person is not in any teams
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.